MilWealth Group’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-10
Closed -$852 129
2021
Q4
$852 Hold
10
﹤0.01% 154
2021
Q3
$960 Buy
+10
New +$960 ﹤0.01% 164